| High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda R Naluyange, G Mboowa, K Komakech, D Semugenze, DP Kateete, ... PloS one 15 (5), e0232543, 2020 | 22 | 2020 |
| In vitro anti-tuberculosis activity of total crude extract of Echinops amplexicaulis against multi-drug resistant Mycobacterium tuberculosis K Kevin, K John, N Carolyn, S Derrick, A Lubega J Health Sci 6, 296-303, 2018 | 8 | 2018 |
| Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda K Komakech, L Nakiyingi, A Fred, B Achan, M Joloba, BJ Kirenga, ... BMC Infectious Diseases 24 (1), 70, 2024 | 4 | 2024 |
| Discordance of the Repeat GeneXpert MTB/RIF test for Rifampicin resistance detection among patients Initiating MDR-TB treatment in Uganda W Ssengooba, J de Dieu Iragena, K Komakech, I Okello, J Nalunjogi, ... Open forum infectious diseases 8 (6), ofab173, 2021 | 4 | 2021 |
| Gut colonization of Enterococcus species is associated with COVID-19 disease in Uganda C Agudelo, DP Kateete, E Nasinghe, R Kamulegeya, C Lubega, ... medRxiv, 2024.09. 28.24314457, 2024 | | 2024 |
| Combination Activity of Standard Antituberculosis Drugs and Extracts of Medicinal Plants Commonly Used in Traditional Treatment of Tuberculosis in Uganda M Mpeirwe, K Komakech, CD Sesaazi, PE Ogwang, J Bazira Advances in Infectious Diseases, 2024 | | 2024 |
| Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda W Ssengooba, K Komakech, S Namiiro, H Byabajungu, J Nalunjogi, ... Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 25, 100286, 2021 | | 2021 |
